Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1

Hyperglycemia Clinical Trial

Official title: Clinical Process Improvement With A Bedside Computerized Insulin Therapy Protocol For Blood Glucose Control (eProtocol-insulin) in Adult And Pediatric ICU Patients:Further Refinement and Validation of eProtocol-insulin

Status Recruiting

Clinical Trial Summary

The Purpose of this study is to:

1. Refine and validate a computerized bedside decision support tool blood glucose management in critically ill adult and pediatric ICU patients.

2. Monitor how often low blood sugar levels occur during use of the bedside tool.

3. Determine how the computerized tool effects the workload of the ICU nurses.

Clinical Trial Description

This first phase will be a prospective cohort study. We will validate the bedside tool in at least 4 adult and at least 4 pediatric ICUs and if necessary we will modify the bedside tool. The computerized bedside tool will be considered refined if >90% of the generated instructions are accepted and if the percent of glucose values in the 70-110 mg/dl range are equivalent to our pilot experience rate of 55%, and if the rate of glucose values less than or equal to 40 mg/dl is less than 0.5% of glucose measurements. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Critical Illness
• Critically Ill
• Hyperglycemia

• NCT number: NCT00655460
• Study type: Interventional
• Source: Intermountain Health Care, Inc.
• Contact: Alan H Morris, MD
• Phone: 801-408-1610
• Email: Alan.Morris@intermountainmail.org
• Status: Recruiting
• Phase: Phase 2
• Start date: February 2006
• Completion date: December 2018